Cardinal Health (CAH) Long-Term Investments (2009 - 2025)
Cardinal Health (CAH) posted Long-Term Investments of $1.2 billion for Q4 2025, up 28.9% sequentially from $910.0 million in Q3 2025.
Cardinal Health (CAH) Long-Term Investments (2009 - 2025) Analysis & Trends
Cardinal Health has reported Long-Term Investments for 5 years, with the latest figure at $1.2 billion in Q4 2025.
- Quarterly Long-Term Investments changed N/A year-over-year to $1.2 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 billion (changed N/A YoY) and the FY2018 annual result came in at $50.0 million, changed N/A from the prior year.
- Long-Term Investments grew to $1.2 billion in Q4 2025 per CAH's latest filing, from $910.0 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $1.2 billion in Q4 2025 and troughed at $147.0 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | - |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | - |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | - |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 604.00 Mn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | - |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | - |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | - |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | - |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.17 Bn |
| Sep 30, 2025 | 910.00 Mn |
| Sep 30, 2023 | 147.00 Mn |
| Sep 30, 2018 | 394.00 Mn |
| Jun 30, 2018 | 50.00 Mn |
| Jun 30, 2010 | 691.50 Mn |
| Mar 31, 2010 | 805.20 Mn |
| Dec 31, 2009 | 897.40 Mn |
| Sep 30, 2009 | 902.40 Mn |